G13.1
✓ Billable
Other systemic atrophy primarily affecting central nervous system in neoplastic disease
ICD-10-CM · FY2026 · Diseases of the Nervous System
Code
G13.1
System
ICD-10-CM
Billable
Yes — valid for submission
Effective
FY2026
Chapter
Diseases of the Nervous System
Source
CMS / CDC NCHS
⚠ Verify before billing. Confirm against the current CMS/NCHS ICD-10-CM files and your payer's rules before claims submission.
Frequently asked questions
What is ICD-10 code G13.1?
ICD-10-CM code G13.1 represents Other systemic atrophy primarily affecting central nervous system in neoplastic disease. It is a billable diagnosis code in the Diseases of the Nervous System chapter, effective October 1, 2025 – September 30, 2026.
Is G13.1 billable?
Yes. G13.1 is a valid billable ICD-10-CM code for insurance claims and clinical documentation.
What chapter is G13.1 in?
G13.1 belongs to the Diseases of the Nervous System chapter (G00–G99) of ICD-10-CM.
Related codes in the G13 category
G13
Systemic atrophies primarily affecting central nervous system in diseases classified elsewhere
Non-billable
G13.0
Paraneoplastic neuromyopathy and neuropathy
Billable
G13.2
Systemic atrophy primarily affecting the central nervous system in myxedema
Billable
G13.8
Systemic atrophy primarily affecting central nervous system in other diseases classified elsewhere
Billable
Search all 98,186 ICD-10-CM codes instantly
Search ICDwise →